IRIS
ROSSI, Davide
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.753
NA - Nord America 6.651
AS - Asia 1.616
Continente sconosciuto - Info sul continente non disponibili 40
SA - Sud America 6
OC - Oceania 1
Totale 15.067
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.618
IE - Irlanda 2.599
DE - Germania 1.162
UA - Ucraina 981
SE - Svezia 942
CN - Cina 777
FI - Finlandia 569
SG - Singapore 380
IT - Italia 305
HK - Hong Kong 275
IN - India 131
GB - Regno Unito 72
EU - Europa 38
IR - Iran 36
CA - Canada 33
FR - Francia 24
BE - Belgio 22
CZ - Repubblica Ceca 22
NL - Olanda 13
RO - Romania 9
RU - Federazione Russa 8
LT - Lituania 7
IL - Israele 5
JP - Giappone 5
CH - Svizzera 4
AL - Albania 3
ES - Italia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AR - Argentina 2
AT - Austria 2
BG - Bulgaria 2
CL - Cile 2
GR - Grecia 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AU - Australia 1
CO - Colombia 1
GE - Georgia 1
ID - Indonesia 1
KR - Corea 1
PE - Perù 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 15.067
Salva come PNG Salva come JPEG
Città #
Dublin 2.599
Jacksonville 1.897
Dearborn 1.007
Wilmington 700
Chandler 379
Lawrence 339
Princeton 339
Beijing 299
Hong Kong 274
San Mateo 256
Singapore 220
Andover 177
Ann Arbor 167
Piemonte 146
Ashburn 127
Boardman 92
Hefei 77
Nanjing 72
Kunming 65
Woodbridge 63
Houston 59
Bremen 47
Norwalk 43
Guangzhou 36
Grafing 32
Düsseldorf 31
Jinan 31
Nanchang 24
Brussels 21
Seattle 21
Fairfield 19
Toronto 19
Helsinki 18
Zanjan 18
Brno 17
Munich 15
Shenyang 15
Milan 14
Leawood 13
Fuzhou 12
Wuhan 10
Frankfurt am Main 9
Berlin 8
Chengdu 8
Hangzhou 8
Horia 8
Sacramento 8
Auburn Hills 7
Ottawa 7
Zhengzhou 7
Chongqing 6
Hebei 6
London 6
Monmouth Junction 6
Shaoxing 6
Torino 6
Winnipeg 6
Baotou 5
Falls Church 5
Gunzenhausen 5
Henderson 5
Lucé 5
Nanning 5
Salerno 5
Shanghai 5
Trieste 5
Augusta 4
Cambridge 4
Casalecchio Di Reno 4
Florence 4
Harbin 4
Leipzig 4
Palermo 4
Philadelphia 4
Santa Clara 4
Somaglia 4
Venaria Reale 4
Asti 3
Brescia 3
Cassano Magnago 3
Dallas 3
Jiaxing 3
Jinhua 3
Kemerovo 3
Novara 3
Palo Alto 3
Taiyuan 3
Ardabil 2
Aversa 2
Bangalore 2
Changsha 2
Clifton 2
Draveil 2
Evansville 2
Guiyang 2
Hyderabad 2
Kocaeli 2
Los Angeles 2
Meppel 2
Monza 2
Totale 10.067
Salva come PNG Salva come JPEG
Nome #
Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosis 112
Analysis of human beta papillomavirus and Merkel cell polyomavirus infection in skin lesions and eyebrow hair bulbs from a cohort of chronic lymphocytic leukaemia patients. 105
Diffuse large B-cell lymphoma genotyping on the liquid biopsy 102
The krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma. 101
Molecular lesions of signalling pathway genes in clonal B-cell lymphocytosis with marginal zone features. 91
Bendamustine and subcutaneous Alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients. 88
Alteration of BIRC3 and multiple other NF-kB pathway genes in splenic marginal zone lymphoma 79
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia 77
Recurrent mutations refine prognosis in chronic lymphocytic leukemia. 76
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas 76
MYC NETWORK MUTATIONS IN HIGH-RISK CHRONIC LYMPHOCYTIC LEUKAEMIA 75
BCL2 MUTATION SPECTRUM IN B-CELL NON-HODGKIN LYMPHOMAS AND PATTERNS ASSOCIATED WITH EVOLUTION OF FOLLICULAR LYMPHOMA 74
Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome 74
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation 73
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome 72
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild type chronic lymphocytic leukemia 72
Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials 71
ASSOCIATION BETWEEN MOLECULAR LESIONS AND SPECIFIC B-CELL RECEPTOR SUBSETS IN CHRONIC LYMPHOCYTIC LEUKEMIA 71
CLINICAL IMPACT OF SMALL TP53 MUTATED SUBCLONES IN CHRONIC LYMPHOCYTIC LEUKEMIA 71
Cryoglobulin-induced IL-1 beta gene expression and procytokine in monocytes from cryoglobulinemic patients. 70
MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia 70
NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment. 70
CLINICAL IMPACT OF SMALL SUBCLONES HARBORING NOTCH1, SF3B1 OR BIRC3 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 69
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow-up 69
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia 68
Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma 68
Analysis of immunoglobulin heavy and light chain variable genes in post-transplant lymfoproliferative disorders 68
Alternative translocation breakpoint cluster region 5' to BCL-6 in B-cell non-Hodgkin's lymphoma 67
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia 67
MOLECULAR PATHOPHYSIOLOGY OF INDOLENT LYMPHOMA 66
Ibrutinib-naïve chronic lymphocytic leukemia lacks Bruton tyrosine kinase mutations associated with treatment resistance. 66
International Prognostic Score for Asymptomatic Early-stage Chronic Lymphocytic Leukemia 66
-Active AKT signaling triggers CLL towards Richter's transformation via over-activation of Notch1 66
Richter syndrome and fludarabine: a controversial relationship 65
Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21 65
Prognostic relevance of MYD88 mutations in CLL: the jury is still out 65
Clues to the pathogenesis of Waldenström Macroglobulinemia and IgM-MGUS provided by the analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors 65
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development 65
Italian external and multicentric validation of the MD Anderson Cancer Center nomogram and prognostic index for chronic lymphocytic leukaemia patients: analysis of 1502 cases. 64
Aberrant somatic hypermutation in post-transplant lymphoproliferative disorders 64
The genetics of nodal marginal zone lymphoma 64
Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia 63
Biology and treatment of Richter syndrome 63
ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia 62
Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma 62
Analysis of NOTCH1 mutations in monoclonal B cell lymphocytosis 62
Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma 62
MOLECULAR CHARACTERIZATION OF COMMON VARIABLE IMMUNODEFICIENCY-RELATED LYMPHOMAS 61
Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia 61
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness 61
CD49d expression is an independent risk factor of progressive disease in early stage chronic lymphocytic leukemia 61
EARLY-STAGE DIFFUSE LARGE B CELL LYMPHOMA OF THE HEAD AND NECK: CLINICO-BIOLOGICAL CHARACTERIZATION AND 18 YEAR FOLLOW-UP OF 488 PATIENTS (IELSG 23 STUDY) 61
Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia. 61
ASPETTI MOLECOLARI DEI LINFOMI ASSOCIATI A HIV 60
Beta-HPV infection and skin cancer in patients suffering from chronic lymphocytic leukemia. 60
ASSOCIATION BETWEEN GENE AND MIRNA EXPRESSION PROFILES AND STEREOTYPED SUBSET #4 B-CELL RECEPTOR IN CHRONIC LYMPHOCYTIC LEUKEMIA. 59
Beta-HPV infection and skin cancer in patients suffering from chronic lymphocytic leukemia. 59
A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment 59
Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment 59
Extramedullary intracranial localization of multiple myeloma and treatment with novel agents: A retrospective survey of 50 patients 58
MOLECULAR BASIS OF TARGET THERAPY FOR AGGRESSIVE B-CELL LYMPHOMA 57
Characterization of a novel HHV-8-positive cell line reveals implications for the pathogenesis and cell cycle control of primary effusion lymphoma 57
GENETIC LESIONS ASSOCIATED WITH CHRONIC LYMPHOCYTIC LEUKEMIA CHEMO-REFRACTORINESS 57
CARATTERIZZAZIONE VIROLOGICA E MOLECOLARE DELLE PATOLOGIE LINFOPROLIFERATIVE POST-TRAPIANTO 56
ALTERAZIONI GENETICHE E INTERAZIONI CON IL MICROAMBIENTE NEI LINFOMI MALIGNI 56
Molecular history of Richter syndrome: Origin from a cell already present at the time of chronic lymphocytic leukemia diagnosis 56
GENETIC ABERRATIONS OF SIGNALING PATHWAYS IN LYMPHOMAGENESIS: REVELATIONS FROM NEXT GENERATION SEQUENCING STUDIES 56
Clinical, pathological, and biological characterization of Richter syndrome developing after ibrutinib treatment for relapsed chronic lymphocytic leukemia 56
Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma. 56
Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease. 56
The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation 55
KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study 55
Molecular histogenesis of plasmablastic lymphoma of the oral cavity 54
Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome 54
EPIGENETIC INACTIVATION OF SUPPRESSORS OF CYTOKINE SIGNALLING IN Ph-NEGATIVE CHRONIC MYELOPROLIFERATIVE DISORDERS 53
14q32 Translocations and risk of Richter transformation in chronic lymphocytic leukaemia 53
Occult hepatitis B virus infection of peripheral blood mononuclear cells among treatment-naïve patients with chronic lymphocytic leukemia 53
Genetic Landscape of Ultra-Stable Chronic Lymphocytic Leukemia Patients 53
Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia 53
Clinical significance of c.7544-7545 delCT NOTCH1 mutation in chronic lymphocytic leukaemia 52
Absence of NOTCH1 gene mutations in MALT lymphomas 52
HBV AND LYMPHOMAGENESIS: NOVEL INSIGHTS INTO AN OCCULT RELATIONSHIP 52
THE HOST GENETIC BACKGROUND OF DNA REPAIR MECHANISMS IS AN INDEPENDENT PREDICTOR OF PROGRESSION AND OVERALL SURVIVAL IN DIFFUSE LARGE B-CELL LYMPHOMA 52
Simian Virus 40 (SV40) infection in lymphoproliferative disorders: A reappraisal based on five hundred cases 51
AGGIORNAMENTI DI PATOGENESI MOLECOLARE DEI LINFOMI HIV-CORRELATI 51
Renal outcome and monoclonal immunoglobulin deposition disease in 289 old patients with blood cell dyscrasias: a single center experience 51
MOLECULAR BASES OF CHRONIC LYMPHOCYTIC LEUKEMIA IN LIGHT OF NEW TREATMENTS 51
RICHTER SYNDROME: FROM MOLECULAR GENETIC TO THERAPEUTIC STRATEGIES 51
Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study 51
Beta-2-microglobulin is an independent predictor of progression in asymptomatic multiple myeloma 50
Saliva is a reliable and practical source of germline DNA for genome-wide studies in chronic lymphocytic leukemia 50
INDOLENT LYMPHOMA: FROM MOLECULAR PATHOGENESIS TO MOLECULAR DIAGNOSIS 50
Renal handling of monoclonal free light chains depends on fractional excretion: study on 1039 serum-urine paired samples of 187 patients 50
Simultaneous diagnosis of CD3+ T-cell large granular lymphocyte leukaemia and true thymic hyperplasia 50
Late relapse in patients with diffuse large B-cell lymphoma: impact of rituximab on their incidence and outcome 50
Role of MYD88 in lymphoplasmacytic lymphoma diagnosis and pathogenesis 49
HLA-G IS A COMPONENT OF THE CLL ESCAPE REPERTOIRE TO GENERATE IMMUNE SUPPRESSION: IMPACT OF HLA-G 14 BP (RS66554220) POLYMORPHISM 49
Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi 49
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia 49
Richter syndrome: Pathogenesis and management 49
Totale 6.286
Salva come PNG Salva come JPEG
Categoria #
all - tutte 94.697
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.697
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.689 0 0 0 0 0 627 886 204 381 237 348 6
2020/20212.057 332 15 328 6 305 20 328 21 332 20 339 11
2021/20221.959 24 12 284 193 154 15 209 31 154 57 363 463
2022/20234.202 356 132 213 60 154 321 98 177 2.532 5 95 59
2023/20241.217 74 68 82 22 238 15 256 29 5 5 81 342
2024/2025308 63 10 68 40 93 34 0 0 0 0 0 0
Totale 15.414